Retinal vein occlusion (RVO) represents a common cause of visual impairment and blindness. RVO may be associated with both local (e.g., hyperopia, glaucoma) and systemic (e.g., hypertension, diabetes, smoking, obesity, and dyslipidaemia) risk factors. The association with thrombophilia remains controversial. Data on the use of antithrombotic therapy for RVO are poor and inconsistent with most of the information being derived from observational studies. Here we provide a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) to guide the clinical and therapeutic management of patients with RVO based on the available evidence and expert opinion

Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) / Paciullo, F.; Valeriani, E.; Porfidia, A.; Di Nisio, M.; Donadini, M. P.; Marcucci, R.; Prisco, D.; Cagini, C.; Gresele, P.; Ageno, W.. - 20:4(2022), pp. 341-347. [10.2450/2022.0276-21]

Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET)

Valeriani E.
Co-primo
;
2022

Abstract

Retinal vein occlusion (RVO) represents a common cause of visual impairment and blindness. RVO may be associated with both local (e.g., hyperopia, glaucoma) and systemic (e.g., hypertension, diabetes, smoking, obesity, and dyslipidaemia) risk factors. The association with thrombophilia remains controversial. Data on the use of antithrombotic therapy for RVO are poor and inconsistent with most of the information being derived from observational studies. Here we provide a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) to guide the clinical and therapeutic management of patients with RVO based on the available evidence and expert opinion
2022
anticoagulant agents; antiplatelet agents; evidence-based medicine; retinal vein occlusion; Fibrinolytic Agents; Hemostasis; Humans; Risk Factors; Retinal Vein Occlusion; Thrombophilia; Thrombosis
01 Pubblicazione su rivista::01a Articolo in rivista
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) / Paciullo, F.; Valeriani, E.; Porfidia, A.; Di Nisio, M.; Donadini, M. P.; Marcucci, R.; Prisco, D.; Cagini, C.; Gresele, P.; Ageno, W.. - 20:4(2022), pp. 341-347. [10.2450/2022.0276-21]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1661277
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact